Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia

スポンサーリンク

概要

• 論文の詳細を見る
• 2004-06-15

著者

• TAUCHI Tetsuzo

  First Department of Internal Medicine (Division of Hematology), Tokyo Medical University

• OHYASHIKI Kazuma

  First Department of Internal Medicine (Division of Hematology), Tokyo Medical University

• Ohyashiki Kazuma

  First Deparmtne Of Internal Medicine Tokyo Medical University

• Tauchi Tetsuzo

  First Department Of Internal Medicine (division Of Hematology) Tokyo Medical University

• OHYASHIKI Kazuma

  First Department of Internal Medicine, Tokyo Medical University

関連論文

• Successful prior treatment with dasatinib followed by stem cell transplantation in a patient with CML in blastic crisis with a BCR-ABL mutation
• Endobronchial Minute Leiomyoma in a Patient with Malignant Lymphoma
• Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells
• Multicenter Prospective Study of Clonal Complications in Adult Aplastic Anemia Patients following Recombinant Human Granulocyte Colony-Stimulating Factor (Lenograstim) Administration
• Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
• Activity of a novel Aurora kinase inhibitor against the T315I mutant form of BCR-ABL : In vitro and in vivo studies
• Sustained Complete Cytogenetic Remission in a Patient with Chronic Myeloid Leukemia after Discontinuation of Imatinib Mesylate Therapy
• Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
• Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload
• Disparity Between the Macroglobulin-Producing Components of 2 Cases of Follicular Lymphoma With Waldenstrom's Macroglobulinemia
• Homeobox genes in hematopoiesis and leukemogenesis
• Myeloid/Natural Killer Cell Precursor Acute Leukemia Accompanied by Homozygous Protein C Deficiency
• Can Eradication Therapy for Helicobacter pylori Really Inprove the Thrombocytopenia in Idiopathic Thrombocytopenic Purpura? Our Experience and a Literature Review
• Thrombocytopenia Induced by Imatinib Mesylate(Glivec) in Patients with Chronic Myelogenous Leukemia : Is 400 mg Daily of Imatinib Mesylate an Optimal Starting Dose for Japanese Patients?
• IgA-λ/IgG-к Biclonal Myeloma in which Two Clones Proliferated in Individual Sites
• A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
• Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
• Leukocytosis is linked to thrombosis at diagnosis, while JAK2 V617F mutation is associated with thrombosis during the course of essential thrombocythemia
• The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
• The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
• Relapse of chronic myeloid leukemia-chronic phase 14 years after allogeneic hematopoietic stem cell transplantation
• BCR/ABL signal transduction
• Non-radioisotopic and Semi-quantitative Procedure for Terminal Repeat Amplification Protocol
• Trisomy 11 Acute Myeloid Leukemia: 5 Additional Cases From the Japan Adult Leukemia Study Group AML-92 and AML-95 Databases
• Hypereosinophilia in a Patient with Invasive Thymoma with Clonal T-Lymphocyte Expansion Expressing CD4, CD8, and CD25 Antigens
• Bone Marrow Cytogenetic Complete Remission Achieved by Interferon-α Plus Cytarabine Ocfosfate Therapy in a Patient With Chronic Myelogenous Leukemia During Extramedullary Blast Crisis
• Myelodysplastic Syndrome Accompanied by Addison's Disease and Multiple Autoimmune Phenomena: Steroid Therapy Resolved Cytopenias and All Immune Disorders
• Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia
• Brain Abscess in Acute Myeloid Leukemia
• Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2^* magnetic resonance
• A Long-Survival Case of Systemic AL Amyloidosis with Nephrotic Syndrome
• Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
• An Adult Case of Acute Disseminated Encephalomyelitis Accompanied with Measles Infection
• The Second Generation of BCR-ABL Tyrosine Kinase Inhibitors
• 5q-syndrome in Japan
• Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

もっと見る 閉じる

スポンサーリンク